Henk‐Jan Westeneng

Author

Henk‐Jan Westeneng

University Medical Center Utrecht ORCID

Also Known As

Armstrong, Nicola J., H J Westeneng, H.-J. Westeneng, Henk-Jan Westeneng, Henk‐Jan Westeneng, Westeneng, Henk-Jan

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University King's College London Heidelberg University University Hospital Heidelberg

About

Henk‐Jan Westeneng is an author at University Medical Center Utrecht specializing in medicine, neuroscience, and neurodegeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	170
2	Neuroscience	4	4	120
3	Neurology	3	3	109
4	Pharmacology	2	2	70
5	Health Sciences	1	1	11

Henk‐Jan Westeneng

Publications

977

Citations

H-Index

Page 1

	Year	Citations
<scp>C</scp>9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits Max Koppers, Anna M. Blokhuis, Henk‐Jan Westeneng, Annals of Neurology	2015	244
Cortical thickness in ALS: towards a marker for upper motor neuron involvement Renée Walhout, Henk‐Jan Westeneng, Esther Verstraete, Journal of Neurology Neurosurgery & Psychiatry	2014	104
Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study Mark R. Janse van Mantgem, Ruben P. A. van Eijk, Hannelore K. van der Burgh, Journal of Neurology Neurosurgery & Psychiatry	2020	85
Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis Anne E Visser, James Rooney, Fabrizio D’Ovidio, Journal of Neurology Neurosurgery & Psychiatry	2018	54
<i>ATXN1</i> repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization Gijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, Brain Communications	2020	53
Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study Henk‐Jan Westeneng, Kevin van Veenhuijzen, Rick A. A. van der Spek, The Lancet Neurology Neurodegenerative DiseasesAmyotrophic Lateral SclerosisC9orf72 GenotypeNeurological DisorderGenetic Epidemiology	2021	52
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy Marta García‐Montojo, Saeed Fathi, Gina Norato, Journal of the Neurological Sciences Amyotrophic Lateral SclerosisNeurovirologyMedicinePharmacologyAntiviral Response	2021	50
<scp>MRI</scp> Clustering Reveals Three <scp>ALS</scp> Subtypes With Unique Neurodegeneration Patterns Harold H G Tan, Henk‐Jan Westeneng, Abram D. Nitert, Annals of Neurology	2022	42
The Distinct Traits of the <i>UNC13A</i> Polymorphism in Amyotrophic Lateral Sclerosis Harold H G Tan, Henk‐Jan Westeneng, Hannelore K. van der Burgh, Annals of Neurology	2020	41
Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort Gijs H.P. Tazelaar, Annelot M. Dekker, Joke J.F.A. van Vugt, Neurobiology of Aging Neurodegenerative DiseasesAmyotrophic Lateral SclerosisLarge International CohortNeurological DisorderNipa1 Repeat Expansions	2018	37

Page 1